Tokyo, Japan — December 10, 2025, 10:00 AM JST — NEC Bio Therapeutics today presents results from the Phase I basket clinical trial of an orally administered cancer vaccine, NECVAX-NEO1, used in combination with…
NEC Presents Oral Cancer Vaccine NECVAX-NEO1 at ESMO Immuno-Oncology Congress 2025: Press Releases
